Verghote, Flor http://orcid.org/0000-0003-2218-1394
Poppe, Lindsay
Verbeke, Sofie
Dirix, Piet
Albersen, Maarten
De Meerleer, Gert
Berghen, Charlien
Ost, Piet
Villeirs, Geert
De Visschere, Pieter
De Man, Kathia
De Maeseneer, Daan
Rottey, Sylvie
Van Praet, Charles
Decaestecker, Karel
Fonteyne, Valérie
Funding for this research was provided by:
kom op tegen kanker
Article History
Received: 1 July 2021
Accepted: 11 October 2021
First Online: 18 October 2021
Declarations
:
: This study is approved by the Ethics Committee of the Ghent University Hospital on 11/5/2020 (BC-07456). Any significant change or addition to the protocol will only be made in a written protocol amendment that is approved by the Ethics Committee. All patients will give their written informed consent before inclusion. This will be obtained after a clear and thorough discussion between the patient and the consenting physician.
: Not applicable.
: VF has received grant funding from Ipsen and has consulted for Ipsen and Janssen, all unrelated to this research project. PO has received grants from Ferring Pharmaceuticals, Merck, Varian and Bayer, has consulted for Ferring Pharmaceuticals, Bayer, Janssen, Curium and Novartis, all unrelated to this research project. VPC has consulted for Astellas, unrelated to this project. The other authors declare that they have no competing interests.